goetzpartners advised a financial investor on the aquisition of the Four Seasons Health Care Group

Fortlane Partners advised

Exyte on the

of TTP Group

value not disclosed

goetzpartners advised

goetzpartners advised the

of Central Glass Germany GmbH

value not disclosed

goetzpartners advised

EvoTec SE on the

of Rigenerand Srl

230,000,00 €

goetzpartners advised

Otto Group on the

of Medgate Holding & Better Doc

value not disclosed

goetzpartners advised

Pharmaron on its

of Aesica Pharmaceuticals from Recipharm

value not disclosed

goetzpartners advised

doctari group on the

of Planerio GmbH

value not disclosed

goetzpartners advised

Pharmaron on its

of Allergan Biologics from AbbVie

value not disclosed

goetzpartners advised

EUSA Pharma on the

of the global commercialization rights to the oncology product ISQETTE

value not disclosed

goetzpartners advised

Penta Investment on the

of Lloyds Pharma

value not disclosed

goetzpartners advised

Penta Investment on the

of Gehe Pharma

value not disclosed

goetzpartners advised

KKR and Triton on the

of Ambea

value not disclosed

goetzpartners advised

Chequers Capital on the

of Silver Care Holding

value not disclosed

goetzpartners advised

TÜV Süd on the

of MSOURCE from its founder, Dr. Adriaan Hart de Ruijter

value not disclosed